Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome- |
RCV001533655 | SCV001750394 | benign | Ataxia-telangiectasia syndrome | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001655825 | SCV001871672 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225847 | SCV002505294 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV001692456 | SCV004101990 | benign | not specified | 2023-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 63% of patients studied by a panel of primary immunodeficiencies. Number of patients: 60. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001655825 | SCV005231003 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics Laboratory, |
RCV001692456 | SCV001906163 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001692456 | SCV001926410 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001692456 | SCV001955821 | benign | not specified | no assertion criteria provided | clinical testing |